Showing results (2461-2470 of 2,820) with videos related to

Sort By:
Pageof 282
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 7, 2024
Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancerJarey H Wang, Matthew P Deek, Adrianna A Mendes, et al.
ESMO Open|February 12, 2022
Consensus for HER2 alterations testing in non-small-cell lung cancerS Ren, J Wang, J Ying, et al.
Leukemia|July 27, 2017
Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapyZ Yao, L Deng, Z Y Xu-Monette, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2024
Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter ApproachCatalina Amador, Dennis D Weisenburger, Ana Gomez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2024
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphomaT M Kim, M Taszner, S Novelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized studyY K Shi, L Wang, B H Han, et al.
European Urology Oncology|June 11, 2024
Genomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate CancerPhilip Sutera, Yang Song, Amol C Shetty, et al.
Cell Genomics|February 21, 2026
Hi-C for genome-wide detection of enhancer-hijacking rearrangements in routine lymphoid cancer biopsiesJamin Wu, Shih-Chun A Chu, Jang Cho, et al.
BMC Cancer|June 4, 2020
A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)Hamza Hasan, Matthew P Deek, Ryan Phillips, et al.
European Urology Oncology|September 21, 2025
Genomic Predictors of Response to Metastasis-directed Therapy With or Without Androgen Deprivation TherapyPhilip Sutera, Kim Van der Eecken, Yang Song, et al.
Pageof 282